You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Jan 17, 2026

Profiling Sensitivity to Targeted Therapies in EGFR-Mutant NSCLC Patient-Derived Organoids
Published on: November 22, 2021
Sebastián Cabrera1, Erico Segovia
1Hospital Clínico de la Universidad de Chile José Joaquín Aguirre, Santiago, Chile.
No abstract available in PubMed .
09:38Establishing Dual Resistance to EGFR-TKI and MET-TKI in Lung Adenocarcinoma Cells In Vitro with a 2-step Dose-escalation Procedure
Published on: August 11, 2017
13:34A Combined 3D Tissue Engineered In Vitro/In Silico Lung Tumor Model for Predicting Drug Effectiveness in Specific Mutational Backgrounds
Published on: April 6, 2016